{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-023240","form_type":"8-K","ticker":"IDXX","cik":"0000874716","company_name":"IDEXX LABORATORIES INC /DE","filed_at":"2022-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.049609+00:00","generated_at":"2026-06-25T02:11:00.190609+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"IDEXX to wind down Russian subsidiary, end direct operations","bullets":["Revenue from Russia represented less than 1% of total 2021 consolidated revenue.","No manufacturing or significant supply arrangements in Russia.","Wind-down includes liquidation of the sole Russian subsidiary and direct operations.","Company providing transition support to impacted Russian employees.","Limited products for human or animal health will continue via third-party distributors."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-023240","json":"https://secwatch.observer/filing/0001564590-22-023240.json","markdown":"https://secwatch.observer/filing/0001564590-22-023240.md","text":"https://secwatch.observer/filing/0001564590-22-023240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874716/000156459022023240/0001564590-22-023240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874716/000156459022023240/idxx-8k_20220614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:11:00.190609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}